These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22087022)

  • 1. Chronic angiotensin receptor blockade suppresses intracardiac angiotensin II in angiotensin II-infused rats.
    Conte D; Viscarra J; Nishiyama A; Ortiz RM
    Exp Biol Med (Maywood); 2011 Dec; 236(12):1449-53. PubMed ID: 22087022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension.
    Kobori H; Prieto-Carrasquero MC; Ozawa Y; Navar LG
    Hypertension; 2004 May; 43(5):1126-32. PubMed ID: 15037565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats.
    Shao W; Seth DM; Navar LG
    Hypertension; 2010 Sep; 56(3):378-83. PubMed ID: 20625079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats.
    Zou LX; Imig JD; von Thun AM; Hymel A; Ono H; Navar LG
    Hypertension; 1996 Oct; 28(4):669-77. PubMed ID: 8843896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor-mediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension.
    Nishiyama A; Seth DM; Navar LG
    J Hypertens; 2003 Oct; 21(10):1897-903. PubMed ID: 14508196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local angiotensin II generation in the rat heart: role of renin uptake.
    Müller DN; Fischli W; Clozel JP; Hilgers KF; Bohlender J; Ménard J; Busjahn A; Ganten D; Luft FC
    Circ Res; 1998 Jan 9-23; 82(1):13-20. PubMed ID: 9440700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin type 1 receptor resistance to blockade in the opossum proximal tubule cell due to variations in the binding pocket.
    Nistala R; Andresen BT; Pulakat L; Meuth A; Sinak C; Mandavia C; Thekkumkara T; Speth RC; Whaley-Connell A; Sowers JR
    Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1105-13. PubMed ID: 23389452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.
    Yao L; Kobori H; Rahman M; Seth DM; Shokoji T; Fan Y; Zhang GX; Kimura S; Abe Y; Nishiyama A
    Hypertens Res; 2004 Jul; 27(7):493-500. PubMed ID: 15302986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
    Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats.
    Padia SH; Kemp BA; Howell NL; Fournie-Zaluski MC; Roques BP; Carey RM
    Hypertension; 2008 Feb; 51(2):460-5. PubMed ID: 18158338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor.
    Zhuo JL; Imig JD; Hammond TG; Orengo S; Benes E; Navar LG
    Hypertension; 2002 Jan; 39(1):116-21. PubMed ID: 11799089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans.
    Gandhi SK; Ryder DH; Brown NJ
    Hypertension; 1996 Dec; 28(6):961-6. PubMed ID: 8952583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats.
    Liu L; Gonzalez AA; McCormack M; Seth DM; Kobori H; Navar LG; Prieto MC
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1195-201. PubMed ID: 21865264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat.
    Padia SH; Howell NL; Siragy HM; Carey RM
    Hypertension; 2006 Mar; 47(3):537-44. PubMed ID: 16380540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.
    Matsuyama N; Tsutsumi T; Kubota N; Nakajima T; Suzuki H; Takeyama Y
    Hypertens Res; 2009 Aug; 32(8):721-6. PubMed ID: 19590505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
    Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
    Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
    Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
    Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.